Sun Pharmaceutical Industries Q2 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,924.90
-17.95 (-0.92%)
-17.95 (-0.92%)Volume36.83 K
Updated: Fri 14 Aug, 2026 | 15:54:24
NSE
1,930-2.00 (-0.10%)
-2.00 (-0.10%)Volume8.81 L
Updated: Fri 14 Aug, 2026 | 15:14:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 11,111.23 | 11,947.01 | -1.65% | 10,106.43 | 9.94% |
| Depreciation/ Amortization | 729.50 | 738.72 | 4.13% | 625.91 | 16.55% |
| Operating Income | 3,367.08 | 3,352.87 | 31.83% | 3,184.96 | 5.72% |
| Net Income | 3,117.95 | 2,894.79 | 36.83% | 3,040.16 | 2.56% |
| Other Operating Expenses Total | 4,634.21 | 4,813.81 | 11.34% | 4,308.62 | 7.56% |
| Net Income Before Taxes | 4,167.61 | 4,098.81 | 31.36% | 3,597.88 | 15.84% |
| Total Revenue | 14,478.31 | 15,299.88 | 4.53% | 13,291.39 | 8.93% |
| Selling/ General/ Admin Expenses Total | 2,764.79 | 3,227.23 | -1.32% | 2,477.70 | 11.59% |
| Diluted Normalized EPS | 13.00 | 12.66 | 13.56% | 12.70 | 2.36% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.